P3 Health Partners Target Price

P3 Health Partners's target price stands at $19. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $19 for PIII implies 79.4% upside versus today's price ($10.31). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how P3 Health Partners's target price evolved across reporting periods, while the comparison chart places PIII next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.